PT  - JOURNAL ARTICLE
AU  - King, Patrick
AU  - Wanyana, Mercy Wendy
AU  - Mayinja, Harriet
AU  - Simbwa, Brenda Nakafeero
AU  - Zalwango, Marie Gorreti
AU  - Kobusinge, Joyce Owens
AU  - Migisha, Richard
AU  - Kadobera, Daniel
AU  - Kwesiga, Benon
AU  - Bulage, Lilian
AU  - Gonahasa, Doreen
AU  - Ahabwe, Peter Babigumira
AU  - Nchoko, Serah
AU  - Salat, Edna
AU  - Weithaka, Freshia
AU  - Gunya, Oscar
AU  - Odhiambo, Fredrick
AU  - Mutabazi, Vincent
AU  - Habimana, Metuschelah
AU  - Twagirimana, Gabriel
AU  - Ndabarinze, Ezechiel
AU  - Manishimwe, Alexis
AU  - Itiakorit, Harriet
AU  - Kadivani, Samuel
AU  - Seib, Katy
AU  - Whitney, Ellen
AU  - Ario, Alex Riolexus
TI  - Cross Border Population Movement Patterns, Kenya, Uganda, and Rwanda, November 2022
AID  - 10.1101/2024.02.16.24302786
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.02.16.24302786
4099  - http://medrxiv.org/content/early/2024/02/20/2024.02.16.24302786.short
4100  - http://medrxiv.org/content/early/2024/02/20/2024.02.16.24302786.full
AB  - Background The frequent population movement across the five East African Countries poses risk of disease spread in the region. A clear understanding of population movement patterns is critical for informing cross-border disease control interventions.We assessed population mobility patterns across the borders of the East African states of Kenya, Uganda, and Rwanda.Methods In November 2022, we conducted Focus Group Discussions (FGDs), Key Informant Interviews (KIIs), and participatory mapping. Participants were selected using purposive sampling and a topic guide used during interviews. Key informants included border districts (Uganda and Rwanda) and county health officials (Kenya). FGD participants were identified from border communities and travellers and these included truck drivers, commercial motorcyclists, and businesspersons. During KIIs and FGDs, we conducted participatory mapping using Population Connectivity Across Borders toolkits. Data were analysed using grounded theory approach using Atlas ti 7 software.Results Different age groups travelled across borders for various reasons. Younger age groups travelled across the border for education, trade, social reasons, employment opportunities, agriculture and mining. While older age groups mainly travelled for healthcare and social reasons. Other common reasons for crossing the borders included religious and cultural matters. Respondents reported seasonal variations in the volume of travellers. Respondents reported using both official (4 Kenya-Uganda, 5 Rwanda-Uganda borders) and unofficial Points of Entry (PoEs) (14 Kenya-Uganda, 20 Uganda-Rwanda) for exit and entry movements on borders. Unofficial PoEs were preferred because they had fewer restrictions like the absence of health screening, and immigration and customs checks. Key destination points (points of interest) included: markets, health facilities, places of worship, education institutions, recreational facilities and business towns. Twenty-eight health facilities (10- Lwakhakha, Uganda, 10- Lwakhakha, Kenya, and 8- Cyanika, Uganda) along the borders were the most commonly visited by the travellers and border communities.Conclusion Complex population movement and connectivity patterns were identified along the borders. These were used to guide cross-border disease surveillance and other border health strategies in the three countries. Findings were used to revise district response and preparedness plans by strengthening community-based surveillance in border communities.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe project was supported by the International Association of National Public Health Institutes (IANPHI), Uganda National Institute of Public Health, and the United States Centres for Disease Control and prevention grant number NU14GH001238. The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the US-Centers for Disease Control and Prevention, the department of health and human services, Makerere University school of Public Health or the Ministry of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Office of the Associate Director for Science at the United States Centers for Disease Control and Prevention determined that this study was not a human subject study with the primary intent of guiding public health planning and practice. This activity was reviewed by United States Centers for Disease Control and was conducted consistent with applicable federal law and Centers for Disease Control policy.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe datasets upon which our findings are based belong to the Uganda Ministry of Health and Uganda National Institute of Public Health. They are publicly available upon request from the Uganda National Institute of Public Health.COVID-19Corona Virus DiseaseDSFPDistrict Surveillance Focal personPoEPoint of EntryWHOWorld Health OrganizationUCVIPUganda COVID-19 Vaccination Implementation Plan